Prophylactic antibiotics in acute pancreatitis: endless debate

Area of Science:

• Gastroenterology
• Infectious Diseases
• Critical Care Medicine

Background:

• Pancreatic infection significantly increases morbidity and mortality in acute pancreatitis.
• Antibiotic use is debated, with consensus on avoiding them in mild cases but considering them for severe pancreatitis to prevent secondary infections.

Purpose of the Study:

• To evaluate the efficacy of prophylactic antibiotics in reducing morbidity and mortality in acute pancreatitis.
• To assess the current evidence on the role of prophylactic antibiotics in managing acute pancreatitis.

Main Methods:

• A non-systematic review of existing evidence, meta-analyses, and randomized controlled trials was performed.
• Analysis focused on the impact of prophylactic antibiotics on patient outcomes in acute pancreatitis.

Main Results:

• Evidence for prophylactic antibiotic benefits in acute pancreatitis is conflicting, with most studies showing minimal advantage.
• Routine antibiotic use was associated with higher mortality (9% vs 0%) and morbidity (36% vs 5%) in the authors' unit.
• Significant differences in mortality (P=0.043) and morbidity (P=0.002) were observed between treated and untreated groups.

Conclusions:

• Antibiotics are recommended for patients with sepsis, infected necrosis, systemic inflammatory response syndrome, multiple organ dysfunction syndrome, or pancreatic/extra-pancreatic infections.
• Prompt antibiotic therapy is advised upon elevated inflammatory markers to prevent secondary pancreatic infections.
• Further research is needed to clarify specific indications and patient groups that benefit from antibiotic treatment in acute pancreatitis.